Envestnet Portfolio Solutions, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Envestnet Portfolio Solutions, Inc.
- $24.4 Billion
- Q2 2025
A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 18,985 shares of HRMY stock, worth $649,097. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,985Holding current value
$649,097% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
288Shares Held
45.6MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$226 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$200 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$161 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$54 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$44.1 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.02B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...